Correlagen is a leading developer of genetic testing that helps physicians to
diagnose disease earlier and more precisely for more tailored treatment.
Founded by researchers from Harvard and Children’s Hospital Boston, Correlagen
provides high-quality testing through the use of automated systems and
sophisticated result interpretation and reporting. Correlagen’s customers
range from private practitioners to researchers at some of the world’s foremost
academic institutions.
NEW:
• |
Cardiomyopathy |
• |
Arrhythmia |
• |
Aortopathy |
• |
Noonan Syndrom and related disorders |
• |
Congenital heart disease |
• |
Early-onset coronary artery disease/hypercholesterolemia |
Test samples will be accepted starting immediately.
Clinical testing will begin on December 1st. Initially, results will be returned
within 12 weeks. Pricing available upon request. Please contact Correlagen
Client Services at (781) 647-0604 or testing@correlagen.com.
ALSO NOW AVAILABLE: EASIER ORDERING AND REPORTING FEATURES AND SERVICES
Our new requisitions significantly shorten
the time it takes to place an order.
Click on a link below to access our
new forms (see Ordering U.S. under each condition):
Our reports have become shorter and more concise, and they are now
available in electronic format through a high-security email platform. Electronic
reports are not only fast and convenient, they also provide ready access to
relevant information through hyperlinks. If you would like to test
drive our new electronic reports, please email us at clientservices@correlagen.com.
Please Note:
Turn-around times for test results are typically 14
days for family tests, 21 days for single-gene tests, and 4-6 weeks for multi-gene
panels. Preliminary reports based on partial sequence results will be released
when a pathogenic variant is found or when the report is more than 10 days
overdue due to technical difficulties with a small part of the sequence.
|
